Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02630472 · ClinicalTrials.gov registry record · Phase 1
Topical Irrigation Therapy for CRS
A Phase 1 study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT02630472: Clinical Trial Phase 1 study, sponsored by University of Pennsylvania.
NCT02630472 is a Phase 1 study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02630472, a Phase 1 study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the physiologic response of quinine-saline irrigations for acute exacerbation of uncomplicated chronic rhinosinusitis following endoscopic sinus surgery. Subjects who have previously had functional endoscopic sinus surgery with acute exacerbation of chronic rhinosinusitis will be randomized to either a quinine-saline or saline-placebo arm. The investigators will measure baseline and follow-up clinical and quality-of-life outcomes for both arms, and then compare the groups at the end of the study period. The investigators' hypothesis is that the participants in the quinine sulfate arm will perform better on all measures as compared to the control arm.
Interventions
- DRUG Placebo
- DRUG Quinine Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-05-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02630472
The ClinicalTrials.gov registry entry for NCT02630472 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02630472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02630472 about?
NCT02630472 is a clinical study titled "Topical Irrigation Therapy for CRS". The purpose of the study is to evaluate the physiologic response of quinine-saline irrigations for acute exacerbation of uncomplicated chronic rhinosinusitis following endoscopic sinus surgery. Subjects who have previously had functional endoscopic sinus surgery with acute exacerbation of chronic rh...
What is the current status of trial NCT02630472?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2015-10. Estimated completion is 2017-05-04.
What interventions are being tested in trial NCT02630472?
The interventions under investigation include: Placebo (DRUG), Quinine Sulfate (DRUG).
Who is sponsoring clinical trial NCT02630472?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.